HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Moore Selected Research

albumin interferon

1/2008Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
8/2006Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa.
1/2006Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Moore Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 07/2002
18Pain (Aches)
01/2022 - 02/2005
4Acute Pain
11/2019 - 08/2005
4Substance-Related Disorders (Drug Abuse)
11/2019 - 07/2011
4Chronic Hepatitis C
11/2007 - 01/2006
3Opioid-Related Disorders (Opiate Addiction)
11/2019 - 07/2011
3Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 05/2015
3Body Weight (Weight, Body)
01/2017 - 08/2014
3Hemorrhage
06/2015 - 01/2007
3Infections
02/2015 - 08/2006
3Lung Neoplasms (Lung Cancer)
01/2015 - 10/2008
3Postoperative Pain
08/2013 - 03/2006
3Asthma (Bronchial Asthma)
05/2009 - 01/2006
3Virus Diseases (Viral Diseases)
03/2006 - 07/2002
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 04/2011
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016 - 05/2015
2Stroke (Strokes)
01/2014 - 08/2005
2Hypersensitivity (Allergy)
10/2010 - 10/2002
2Xerostomia
01/2008 - 01/2003
2Atopic Dermatitis (Atopic Eczema)
03/2006 - 11/2002
2Psoriasis (Pustulosis Palmaris et Plantaris)
03/2006 - 11/2002
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Cytokine Release Syndrome
12/2020
1Chronic Pain
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Lymphoma (Lymphomas)
01/2018
1Leukemia
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Colonic Neoplasms (Colon Cancer)
01/2018
1Opiate Overdose
05/2017
1Thyrotoxicosis
11/2016
1Burns
01/2016
1Bradycardia
06/2015

Drug/Important Bio-Agent (IBA)

11Opioid Analgesics (Opioids)IBA
01/2022 - 10/2010
9Analgesics (Analgesic Drugs)IBA
01/2019 - 02/2005
9Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2004
7Local AnestheticsIBA
06/2015 - 03/2006
6Ibuprofen (Motrin)FDA LinkGeneric
01/2018 - 08/2005
6Acetaminophen (Paracetamol)FDA LinkGeneric
01/2018 - 05/2006
5AntigensIBA
12/2020 - 06/2010
5Epinephrine (Adrenaline)FDA LinkGeneric
01/2017 - 03/2006
4AntibodiesIBA
01/2022 - 07/2002
4Bispecific AntibodiesIBA
01/2018 - 06/2010
4Pharmaceutical PreparationsIBA
11/2016 - 01/2007
4Anesthetics (Anesthetic Agents)IBA
01/2016 - 10/2002
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2016 - 08/2005
4InterferonsIBA
01/2008 - 01/2006
4Interferon-alpha (Interferon Alfa)IBA
11/2007 - 01/2006
3Biomarkers (Surrogate Marker)IBA
01/2015 - 10/2008
3Hydrocodone (Dihydrocodeinone)FDA LinkGeneric
08/2013 - 05/2006
3Naproxen (Naprosyn)FDA LinkGeneric
08/2013 - 08/2005
3albumin interferonIBA
01/2008 - 01/2006
3rofecoxib (Vioxx)FDA Link
12/2006 - 02/2005
2Immunoconjugates (Immunoconjugate)IBA
01/2022 - 11/2020
2CytokinesIBA
12/2020 - 01/2018
2Lidocaine (Xylocaine)FDA LinkGeneric
01/2017 - 03/2006
2Prescription DrugsIBA
01/2016 - 04/2011
2Warfarin (Coumadin)FDA LinkGeneric
06/2015 - 01/2007
2Monoclonal AntibodiesIBA
07/2012 - 01/2011
2Oxycodone (Oxycontin)FDA LinkGeneric
10/2010 - 01/2007
2Biological ProductsIBA
06/2010 - 07/2002
2AllergensIBA
05/2009 - 08/2006
2Antiviral Agents (Antivirals)IBA
11/2007 - 01/2006
2Celecoxib (Celebrex)FDA Link
01/2007 - 08/2005
2interferon kappaIBA
03/2006 - 11/2002
1cyclopropapyrroloindoleIBA
01/2022
1pembrolizumabIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1DuocarmycinsIBA
11/2020
1Glycoproteins (Glycoprotein)IBA
01/2018
1Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
01/2018
1Granzymes (Granzyme)IBA
01/2018
1PerforinIBA
01/2018
1Naloxone (Narcan)FDA LinkGeneric
05/2017
1OxymetazolineFDA Link
11/2016
1Cadherins (E-Cadherin)IBA
03/2016
1PF-06671008IBA
03/2016
1Interleukin-3 Receptor alpha SubunitIBA
01/2016
1InterleukinsIBA
01/2016
1SoilIBA
01/2016
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
06/2015
1Propranolol (Inderal)FDA LinkGeneric
06/2015
1Fluconazole (Zonal)FDA LinkGeneric
06/2015
1Metronidazole (Metric)FDA LinkGeneric
06/2015
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2015
1TabletsIBA
02/2015
1Conditioned Culture MediaIBA
01/2015
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2015
1antigen CYFRA21.1IBA
01/2015
12,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)IBA
08/2014

Therapy/Procedure

13Therapeutics
12/2020 - 07/2002
4Local Anesthesia
04/2018 - 10/2002
3Immunotherapy
12/2020 - 05/2015
2Anesthesia
01/2014 - 03/2006
1Pain Management
11/2019
1Contraindications
11/2016
1Oral Surgery (Maxillofacial Surgery)
12/2015
1Drug Therapy (Chemotherapy)
08/2013